Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malka

Showing results (101-110 of 192) with videos related to

Pageof 20
Sort By:
Endocrine-Related Cancer|February 26, 2009
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinomaCosimo Durante, Houda Boukheris, Clarisse Dromain, et al.
The Oncologist|June 19, 2012
Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinomaValérie Boige, David Malka, Abderrahmane Bourredjem, et al.
Radiology|July 26, 2006
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluationThierry de Baère, Jean Palussière, Anne Aupérin, et al.
The Lancet. Oncology|July 5, 2005
Cutaneous side-effects of kinase inhibitors and blocking antibodiesCaroline Robert, Jean-Charles Soria, Alain Spatz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastasesAlice Boilève, Astrid De Cuyper, Alicia Larive, et al.
Neurosurgery|April 9, 2015
An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case ReportBadih Daou, Marc Zanello, Pascale Varlet, et al.
Biomedicines|September 28, 2023
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsAnthony Tarabay, Alice Boileve, Cristina Smolenschi, et al.
Clinical Colorectal Cancer|January 2, 2019
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best PracticeTanios Bekaii-Saab, Richard Kim, Tae Won Kim, et al.
Annals of Surgery|December 14, 2012
Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapyDiane Goéré, Léonor Benhaim, Stéphane Bonnet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2024
Clinical care pathways of patients with biliary tract cancer: A French nationwide longitudinal cohort studyStylianos Tzedakis, Alexandre Challine, Sandrine Katsahian, et al.
Pageof 20

Showing results (101-110 of 192) with videos related to

Sort By:
Pageof 20
Endocrine-Related Cancer|February 26, 2009
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinomaCosimo Durante, Houda Boukheris, Clarisse Dromain, et al.
The Oncologist|June 19, 2012
Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinomaValérie Boige, David Malka, Abderrahmane Bourredjem, et al.
Radiology|July 26, 2006
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluationThierry de Baère, Jean Palussière, Anne Aupérin, et al.
The Lancet. Oncology|July 5, 2005
Cutaneous side-effects of kinase inhibitors and blocking antibodiesCaroline Robert, Jean-Charles Soria, Alain Spatz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastasesAlice Boilève, Astrid De Cuyper, Alicia Larive, et al.
Neurosurgery|April 9, 2015
An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case ReportBadih Daou, Marc Zanello, Pascale Varlet, et al.
Biomedicines|September 28, 2023
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsAnthony Tarabay, Alice Boileve, Cristina Smolenschi, et al.
Clinical Colorectal Cancer|January 2, 2019
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best PracticeTanios Bekaii-Saab, Richard Kim, Tae Won Kim, et al.
Annals of Surgery|December 14, 2012
Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapyDiane Goéré, Léonor Benhaim, Stéphane Bonnet, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2024
Clinical care pathways of patients with biliary tract cancer: A French nationwide longitudinal cohort studyStylianos Tzedakis, Alexandre Challine, Sandrine Katsahian, et al.
Pageof 20